Log in
Email Address
Password
Forgot your password?
Not Registered?

Blog Spot

SMWcroppednew

Name: Stewart Watkins, Managing Director

Company: CDDC

PETEC, owned and managed by the Centre for Process Innovation (CPI), is the national flagship facility for the development and exploitation of direct write technologies and flexible functional materials. It is one of only four such centres in the world.

Click here to read the full blog

Featured Tenant

deburca


deBurca is a software development and integration company that specialises in creating, implementing and supporting innovative applications for e-learning and eBusiness.

Click here to learn more about deBurca

Featured Opportunity
An Improved Microgripper for Cell Manipulation.

There is a growing need for individual cell manipulation in a wide range of research applications including stem cell sorting, gene and molecular delivery, cellular diagnostics, and single cell-based assays.

For further information click here

Polls



CDEP logo Durham County Council Logo

cddc European Union emblem


Oneaboutnetparknet logo


NETPark Net has received funding from Durham County Council through County Durham Development Company, and One NorthEast through the County Durham Sub Regional Partnership. Project Part-Financed by the European Union. European Regional Development Fund.

UK biotech firm on award shortlist


Bookmark and Share Add This     Email notification Email a Friend    print Printable version

UK biotech firm on award shortlist

2008-08-27
Newsfeed

Cambridge-based biotechnology company Astex Therapeutics has been named as one of three finalists for the 100,000-euro European Biotechnica Award 2008.

Cambridge-based biotechnology company Astex Therapeutics has been named as one of three finalists for the 100,000-euro European Biotechnica Award 2008.

The company researches and develops small-molecule drugs, including five that are now being tested for use against cancer. Three are undergoing clinical trials and two are in pre-clinical development.

In addition to its research programs, Astex`s also focusses on developing partnerships with reputable pharmaceutical companies.

The other two finalists are German biotech companies Geneart and immatics. This year will mark the sixth anniversary of the award presented by Deutsche Messe and partners.

Spokesman Stephan Kühne said: "Innovation capacity is the driving force behind the economic success of one of the most important sectors of the future.

"With the European Biotechnica Award, we are supporting upcoming biotechnology firms which, thanks to their dedication, make a significant contribution to the development of Europe as a research location."

Professor Dr Peter Stadler, chairman of the international jury that nominated the companies, said: "All three have shown proof of excellent business expertise, while their products, services and business ideas are certainly a valuable asset to the European biotechnology sector."

Copyright © The Press Association 2008



Add Comment | View Comments (0)


Related Links